HPV Clearance Tied to Cervical Cancer Disparity

Key points
- High-risk human papillomavirus (HPV) infection persisted significantly more often in young African-American women than in white women, suggesting an explanation for the increased cervical cancer risk in African Americans, investigators reported at the American Association for Cancer Research meeting.
- Although the rate of cervical cancer has declined among both Caucasian and African-American women over the past decades, it remains much more prevalent in African-Americans - whose death rates are twice as high as Caucasian women.
- Human papilloma virus (HPV) is the main risk factor for cervical cancer.
- More than twice as many African-American women continued to test positive for high-risk HPV strains two years after diagnosis, and they were 70% more likely than white women to have abnormal Pap smears.
High-risk human papillomavirus (HPV) infection persisted significantly more often in young African-American women than in white women, suggesting an explanation for the increased cervical cancer risk in African Americans, investigators reported at the American Association for Cancer Research meeting.
More than twice as many African-American women continued to test positive for high-risk HPV strains two years after diagnosis, and they were 70% more likely than white women to have abnormal Pap smears.
Because the incidence of HPV infection was similar in African-American and white women, slower viral clearance was the most likely explanation for persistent infection, according to Kim Creek, PhD, of the South Carolina College of Pharmacy in Charleston, and colleagues.
"We propose that an increase in high-risk HPV persistence in African-American women may provide a biological basis for the higher incidence of cervical cancer found in African-American women," Creek said at an AACR press briefing.
"The reason for slower clearance of high-risk HPV infection in African-American participants is unknown and is actively being studied."
Incidence and Prevalence of Cervical Cancer Cancer of the cervix is the second most common cancer in women worldwide and is a leading cause of cancer-related death in women in underdeveloped countries. Worldwide, approximately 500,000 cases of cervical cancer are diagnosed each year.
Routine screening has decreased the incidence of invasive cervical cancer in the United States, where approximately 13,000 cases of invasive cervical cancer and 50,000 cases of cervical carcinoma in situ (i.e., localized cancer) are diagnosed yearly.
Invasive cervical cancer is more common in women middle aged and older and in women of poor socioeconomic status, who are less likely to receive regular screening and early treatment. In the United States, there is also a higher rate of incidence among African American, Hispanic, and Native American women.
African-American women have a 40% higher incidence of cervical cancer and are more than twice as likely white women to die of the disease. Women in the two racial groups have similar rates of screening Pap smears, leading to speculation that the increased cervical cancer risk in African-American women has a biologic basis, said Creek.
To search for a such an explanation, Creek and colleagues analyzed data from the Carolina Women's Care Study, a 5-year investigation of HPV infection in young women.
The study involved 326 European-American women and 113 African-American women enrolled at the University of South Carolina. All of the women were sexually active, and study participants had Pap smears every six months for the duration of their enrollment.
What are the key statistics about cervical cancer? The American Cancer Society's most recent estimates for cervical cancer in the United States are for 2012:
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsProstate cancer hormonal therapy tied to kidney risks
Men who are treated for prostate cancer with hormone-targeted therapy have a higher risk of developing kidney problems, a new study suggests. The treatment, known as androgen deprivation therapy, lowers the risk of…
17 July 2013
NewsPhysicians slow to implement HPV vaccination and cervical cancer screening guidelines
Recent breakthroughs in cervical cancer prevention have resulted in new vaccination and cervical cancer screening guidelines. Recommendations do not always translate into practice, however. Less than one third of…
9 July 2013
NewsRed meat tied to worse colon cancer outcomes: study
People who report eating the most red and processed meat before being diagnosed with colon cancer are more likely to die during the next eight years, according to a new study. "It's another important reason to follow…






